04-23-2026, 08:02 PM
|
#188 (permalink)
|
|
Groupie
Join Date: Aug 2025
Posts: 262
|
https://www.youtube.com/watch?v=X5Oo94XszI0
Quote:
[00:00:10] Opening of the Malcolm and Carolyn Wiener Annual Lecture on Science and Technology.
[00:02:45] Historical context of U.S. preeminence in biomedical research since World War II.
[00:04:02] Statement on why American scientific leadership is no longer guaranteed.
[00:06:04] Introduction of the panelists: Senator Todd Young, Dr. Alicia Jackson, and Dr. Akhila Kosaraju.
[00:08:08] Analysis of China's 20-year strategic prioritization of biotechnology.
[00:09:54] Discussion on protecting the American biotech innovation enterprise.
[00:11:05] Observations on China's ability to train a specialized biotech workforce.
[00:12:16] The need for a centralized biotech authority within the White House.
[00:13:33] Recommendation to treat biotech data as a strategic national asset.
[00:14:54] Status of legislative recommendations moving through Congress.
[00:17:10] Explanation of the ARPA-H model and its origin in response to technological competition.
[00:18:25] Insight into the role of Program Managers in driving high-risk, high-reward research.
[00:20:06] Statistics on Western pharma licensing novel molecules from China.
[00:21:43] Comparison of the 15-year U.S. drug development timeline vs. faster Chinese trials.
[00:24:22] How generative AI is acting as a "light switch" for biotech possibilities.
[00:25:09] Goal to reduce drug development timeframes to five years or less.
[00:28:25] Lessons learned from the 2022 amoxicillin shortage and supply chain vulnerabilities.
[00:32:52] National security applications, such as developing shelf-stable blood for the military.
[00:35:21] Discussion on the "brain drain" and the necessity of a talent pipeline.
[00:41:01] Assessment of the U.S. current competitive advantage in foundational AI models.
|
|
|
|